TechCrunch interviews founders of NewLimit after it received another $40m of funding
TechCrunch - 16-May-2023Reprogramming the epigenetics of a cell could reverse a significant amount of the functional decline that we see with age
Brian Armstrong
Co-founder of NewLimit
Brian Armstrong is the co-founder of NewLimit, an ambitious new company focused on radically extending human healthspan using epigenetic reprogramming therapies. Previously, he worked as a software engineer at Airbnb, a consultant at Deloitte, and co-founded an education company, UniversityTutor, which was acquired in 2014.
He holds a masters degree in computer science and a bachelors degree in economics from Rice University.
Visit website: https://www.brianarmstrong.org/
See also: 
NewLimit
- Company focused on human health and Rejuvenation
Details last updated 19-Dec-2021
Brian Armstrong News
Coinbase CEO selling 2% of his shares to free up over $50m for longevity investments
Lifespan.io (LEAF) - 25-Oct-2022There is a strange overlap in interests between crypto people and longevists - and long may that benefit the industry!
NewLimit, a new biotech launches to slowdown or reverse ageing
NewLimit - 12-Dec-2021Aims to extend healthspan and cure ageing with affordable epigenetic therapies
